NIH funding

The firm will use the funding to build a high-throughput flow cytometry system that sorts cells based on high-content 3D features.

The firm will validate a model system for test development, integrate key test components, and compare Spotlight to other NIPT assays.

Using 350 human genomes from different populations, the two centers plan to develop a multi-genome reference sequence that is as complete as possible.

The award will fund optimization of the Hemopurifier exosome isolator, with an eye towards developing applications in cancer research and clinical care.

Funded projects will look at the combination of imaging and liquid biopsies for monitoring cancer patient responses and the emergence of treatment resistance.

The team will create a group called the Extracellular RNA Communication Consortium Stage 2 to develop new EV-based technology and treat diseases.

The award will help fund development of the firm's "ksim" algorithm to determine infection relatedness in suspected hospital-acquired infection outbreaks.

The two-year award will fund development and commercialization of the firm's HLS-Catch platform and follows a previous grant of $191,535.

The bill would increase funding for a number of NIH projects including the All of Us precision medicine initiative and the BRAIN initiative.